Clariant and private investment firm CD&R are in talks to acquire Ashland in an all-cash deal valuing the company at $3.39B, Bloomberg News reported on Sunday. The potential transaction follows pressure from activist investors who argued the target was undervalued. The deal would reshape the specialty chemicals sector in the United States.
Clariant and CD and R in Ashland Buyout Talks
Swiss specialty chemicals maker Clariant and private investment firm CD and R are in talks to acquire Ashland in an all cash deal valued at about 3.39 billion dollars. Ashland put itself up for sale in July after facing pressure from activist investors.
Insights:











